OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 623

A Current Update on Human Papillomavirus-Associated Head and Neck Cancers
Ebenezer Tumban
Viruses (2019) Vol. 11, Iss. 10, pp. 922-922
Open Access | Times Cited: 201

Virus-like Particle Vaccines and Platforms for Vaccine Development
Jamil Kheirvari Khezerloo, Hong Liu, Ebenezer Tumban
Viruses (2023) Vol. 15, Iss. 5, pp. 1109-1109
Open Access | Times Cited: 58

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Wenbo Ning, Yan Sheng, Yingquan Song, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2

Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded
Sogand Amiri, Shiva Rasekh, Seyed Mohammad Iman Moezzi, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 2

Biological Nanoparticles in Vaccine Development
Stephanie M. Curley, David Putnam
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 45

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 479-479
Open Access | Times Cited: 28

Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 11

Nanocarrier vaccine therapeutics for global infectious and chronic diseases
Faizan Zarreen Simnani, Dibyangshee Singh, Paritosh Patel, et al.
Materials Today (2023) Vol. 66, pp. 371-408
Open Access | Times Cited: 20

A review and new perspective on oral bacteriophages: manifestations in the ecology of oral diseases
Xinyu Guo, Xiaowan Wang, Jia Shi, et al.
Journal of Oral Microbiology (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
Rashi Yadav, Lukai Zhai, Ebenezer Tumban
Viruses (2019) Vol. 12, Iss. 1, pp. 18-18
Open Access | Times Cited: 54

Advancements in protein nanoparticle vaccine platforms to combat infectious disease
Nina Butkovich, Enya Li, A. Gonzaga Ramírez, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2020) Vol. 13, Iss. 3
Open Access | Times Cited: 47

Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines
Acharya Balkrishna, Vedpriya Arya, Akansha Rohela, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1129-1129
Open Access | Times Cited: 39

Potential Applications of Thermophilic Bacteriophages in One Health
Hong Liu, Jamil Kheirvari Khezerloo, Ebenezer Tumban
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8222-8222
Open Access | Times Cited: 14

Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells
Antonina Naskalska, Jonathan G. Heddle
Nanomedicine (2024) Vol. 19, Iss. 12, pp. 1103-1115
Open Access | Times Cited: 6

Advancements in Functional Nanomaterials Inspired by Viral Particles
Xianxun Sun, Yindong Lian, Tao Tian, et al.
Small (2024)
Closed Access | Times Cited: 5

The Role of Virus-Like Particles in Medical Biotechnology
Mauricio Comas-García, Mayra Colunga-Saucedo, Sergio Rosales‐Mendoza
Molecular Pharmaceutics (2020) Vol. 17, Iss. 12, pp. 4407-4420
Closed Access | Times Cited: 37

Bacteriophage Technology and Modern Medicine
Aa Haeruman Azam, Xin-Ee Tan, Srivani Veeranarayanan, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 999-999
Open Access | Times Cited: 33

HPV Infection and Oral Microbiota: Interactions and Future Implications
Qingqing Xia, Sandrine Pierson
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1424-1424
Open Access

Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas
D. Tsakogiannis, Marios Nikolaidis, Flora Zagouri, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 141-141
Open Access | Times Cited: 15

Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Ankita Saha, Sounak Ghosh Roy, Richa Dwivedi, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 424-424
Open Access

Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles
Yuanzheng Wu, Jishun Li, Hyun‐Jae Shin
Biotechnology and Bioprocess Engineering (2021) Vol. 26, Iss. 1, pp. 25-38
Open Access | Times Cited: 19

Page 1 - Next Page

Scroll to top